Many essential drugs priced much higher than manufacturing cost: WHO

According to World Health Organisation (WHO),around 40% of the essential medicines in India are priced significantly higher than estimated production costs.This shows the amount of profiteering done by pharmaceutical companies and the scope for lowering the prices of drugs. The drugs used for cancer,hepatitis C and off patent drugs which are in the market for… Continue reading Many essential drugs priced much higher than manufacturing cost: WHO

Blog
Academy
Community